The Next Generation Biotech Media
In recent times, several big pharma have collaborated with small companies in the immuno-oncology field. Last September, Pfizer made a $200 million investment to collaborate with CStone Pharmaceuticals. Now Novartis …
Read More
At the 39th JPMorgan Healthcare Conference, Eli Lilly discussed how 2020 taught the firm to manage large scale clinical trials remotely. Despite the expectations, Eli Lilly saw a surprisingly low …
Read More
On December 23rd, Israel-based Compugen, a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, achieved a preclinical milestone in developing bispecific and multi-specific antibody products with AstraZeneca. …
Read More
On December 23rd, Roche announced that it had received approval for the usage of Phesgo, a therapy containing two monoclonal antibodies against the human epidermal growth factor receptor 2 (HER2) …
Read More
By Daniel Ojeda, Ph.D. During the IDWeek, an annual scientific conference organized in part by the Infectious Diseases Society of America (IDSA), Vir Biotechnology will present pre-clinical efficacy and preliminary …
Read More
By Sangeeta Chakraborty, Ph.D. Indianapolis-based Eli Lilly’s leading antibody treatment for coronavirus, currently in three major clinical trials, recently came under the scrutiny of government health officials who asked the …
Read More
By Pavel Ryzhov, Ph.D. The clinical trial landscape for COVID-19 treatment options has been steadily growing as the pandemic enters the fourth quarter of 2020. Many companies, including Gilead, Regeneron, …
Read More
By Judy Ya-Hsuan Lin Cancerous tumors create highly specific conditions in their growth environment that are not present in normal tissues. Their established specificity allows researchers to develop safer therapeutic …
Read More
By T. Chakraborty, Ph.D. Osteogenesis Imperfecta (OI) is a rare disorder that affects the connective tissues in the body. It is characterized by extremely fragile bones that break easily, reduced …
Read More
By Judy Ya-Hsuan Lin Both esophageal and gastric cancers are among the top ten cancers and were responsible for over half a million new cases and deaths in 2018. According …
Read More